BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16088507)

  • 1. Hematologic changes in sepsis and their therapeutic implications.
    Goyette RE; Key NS; Ely EW
    Semin Respir Crit Care Med; 2004 Dec; 25(6):645-59. PubMed ID: 16088507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hematologic system as a marker of organ dysfunction in sepsis.
    Aird WC
    Mayo Clin Proc; 2003 Jul; 78(7):869-81. PubMed ID: 12839083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ dysfunction in patients with severe sepsis.
    Vincent JL
    Surg Infect (Larchmt); 2006; 7 Suppl 2():S69-72. PubMed ID: 16895511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual cause of multiple organ dysfunction syndrome in the pediatric intensive care unit: hemophagocytic lymphohistiocytosis.
    Karapinar B; Yilmaz D; Balkan C; Akin M; Ay Y; Kvakli K
    Pediatr Crit Care Med; 2009 May; 10(3):285-90. PubMed ID: 19433941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematologic changes associated with infection.
    McKenzie SB; Laudicina RJ
    Clin Lab Sci; 1998; 11(4):239-51. PubMed ID: 10182113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bleeding events and mortality in SCT patients: a retrospective study of hematopoietic SCT patients with organ dysfunctions due to severe sepsis or GVHD.
    Holler E; Kolb HJ; Greinix H; Perrotin D; Campilho F; Aversa F; Gil L; Cornelissen J; Varanese L; Schacht A; Friese A; Rustige J
    Bone Marrow Transplant; 2009 Mar; 43(6):491-7. PubMed ID: 19079317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mitochondrial permeability transition prevents sepsis-induced myocardial dysfunction and mortality.
    Larche J; Lancel S; Hassoun SM; Favory R; Decoster B; Marchetti P; Chopin C; Neviere R
    J Am Coll Cardiol; 2006 Jul; 48(2):377-85. PubMed ID: 16843190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiology of sepsis--will the basic research contribute to the improvement of outcome in clinical sepsis?].
    Karima R
    Masui; 2008 Mar; 57(3):278-93. PubMed ID: 18340996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in cell signaling in sepsis.
    Abraham E
    Clin Infect Dis; 2005 Nov; 41 Suppl 7():S459-64. PubMed ID: 16237648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular biology on the ICU. From understanding to treating sepsis.
    Winning J; Claus RA; Huse K; Bauer M
    Minerva Anestesiol; 2006 May; 72(5):255-67. PubMed ID: 16675935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early alterations of red blood cell rheology in critically ill patients.
    Reggiori G; Occhipinti G; De Gasperi A; Vincent JL; Piagnerelli M
    Crit Care Med; 2009 Dec; 37(12):3041-6. PubMed ID: 19770749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome.
    Wang H; Ma S
    Am J Emerg Med; 2008 Jul; 26(6):711-5. PubMed ID: 18606328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection.
    Shapiro N; Howell MD; Bates DW; Angus DC; Ngo L; Talmor D
    Ann Emerg Med; 2006 Nov; 48(5):583-90, 590.e1. PubMed ID: 17052559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sepsis, coagulation, and antithrombin: old lessons and new insights.
    Levi M; Schouten M; van der Poll T
    Semin Thromb Hemost; 2008 Nov; 34(8):742-6. PubMed ID: 19214912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepsis and the heart.
    Merx MW; Weber C
    Circulation; 2007 Aug; 116(7):793-802. PubMed ID: 17698745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sepsis: time has come to focus on the later stages.
    Schefold JC; Hasper D; Volk HD; Reinke P
    Med Hypotheses; 2008 Aug; 71(2):203-8. PubMed ID: 18448264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-associated disease: hematologic dysfunction.
    Vandendries ER; Drews RE
    Crit Care Clin; 2006 Apr; 22(2):347-55, viii. PubMed ID: 16678004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sepsis and multiple organ dysfunctions--pathophysiology and the topical concepts of treatment].
    Winter V; Czeslick E; Sablotzki A
    Anesteziol Reanimatol; 2007; (5):66-72. PubMed ID: 18062092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pathogenesis and management of severe sepsis after burns].
    Yao YM; Sheng ZY; Chai JK
    Zhonghua Shao Shang Za Zhi; 2008 Oct; 24(5):337-9. PubMed ID: 19103010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic abnormalities in patients with severe preeclampsia.
    Heilmann L; Rath W; Pollow K
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):285-91. PubMed ID: 17636190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.